A. Niiranen

1.4k total citations
20 papers, 576 citations indexed

About

A. Niiranen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Niiranen has authored 20 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in A. Niiranen's work include Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Niiranen is often cited by papers focused on Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). A. Niiranen collaborates with scholars based in Finland and United States. A. Niiranen's co-authors include K. Mattson, Seppo Pyrhönen, Kari Cantell, Paul Holsti, Mauri Kouri, Lars R. Holsti, Martti Färkkilâ, M Salmo, E. Kumpulainen and Ritva Laaksonen and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

A. Niiranen

19 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Niiranen Finland 13 321 237 142 81 50 20 576
Sonia L. Villegas United States 15 117 0.4× 95 0.4× 60 0.4× 272 3.4× 20 0.4× 25 654
Renata Talar‐Wojnarowska Poland 16 358 1.1× 52 0.2× 160 1.1× 180 2.2× 25 0.5× 75 739
Carlos Vargas Colombia 12 249 0.8× 307 1.3× 47 0.3× 289 3.6× 104 2.1× 56 812
Fausto Rossini Italy 15 339 1.1× 34 0.1× 75 0.5× 230 2.8× 14 0.3× 44 700
Manabu Nagata Japan 11 60 0.2× 107 0.5× 46 0.3× 124 1.5× 23 0.5× 31 399
Richard Petrillo United States 8 87 0.3× 45 0.2× 65 0.5× 337 4.2× 22 0.4× 16 606
Franca Marino Italy 10 103 0.3× 42 0.2× 110 0.8× 80 1.0× 11 0.2× 17 463
Pelayo González Spain 16 100 0.3× 48 0.2× 63 0.4× 211 2.6× 26 0.5× 23 698
Helen Gray United Kingdom 8 53 0.2× 28 0.1× 151 1.1× 69 0.9× 15 0.3× 12 483

Countries citing papers authored by A. Niiranen

Since Specialization
Citations

This map shows the geographic impact of A. Niiranen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Niiranen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Niiranen more than expected).

Fields of papers citing papers by A. Niiranen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Niiranen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Niiranen. The network helps show where A. Niiranen may publish in the future.

Co-authorship network of co-authors of A. Niiranen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Niiranen. A scholar is included among the top collaborators of A. Niiranen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Niiranen. A. Niiranen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Iivanainen, M., Ritva Laaksonen, Mikko Niemi, et al.. (2009). Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 72(5). 475–480. 9 indexed citations
3.
Ruotsalainen, Tarja, Maija Halme, A. Niiranen, et al.. (1999). Concomitant Chemotherapy and IFN-alpha for Small Cell Lung Cancer: A Randomized Multicenter Phase III Study. Journal of Interferon & Cytokine Research. 19(3). 253–259. 25 indexed citations
4.
Mattson, K., A. Niiranen, Tarja Ruotsalainen, et al.. (1997). Interferon Maintenance Therapy for Small Cell Lung Cancer: Improvement in Long-Term Survival. Journal of Interferon & Cytokine Research. 17(2). 103–105. 29 indexed citations
5.
Mattson, K., A. Niiranen, Seppo Pyrhönen, et al.. (1992). Natural interferon alfa as maintenance therapy for small cell lung cancer. European Journal of Cancer. 28(8-9). 1387–1391. 65 indexed citations
6.
Niiranen, A., et al.. (1992). Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study.. Journal of Clinical Oncology. 10(12). 1927–1932. 138 indexed citations
7.
Mattson, K., A. Niiranen, Seppo Pyrhönen, Martti Färkkilâ, & Kari Cantell. (1991). Recombinant interferon Gamma Treatment in Non-Small Cell Lung Cancer Antitumour Effect and Cardiotoxicity. Acta Oncologica. 30(5). 607–610. 17 indexed citations
8.
Mattson, K., A. Niiranen, Paul Holsti, et al.. (1991). Natural alpha interferon as maintenance therapy for small cell lung cancer. Lung Cancer. 7. 127–127. 7 indexed citations
9.
Niiranen, A., Lars R. Holsti, Kari Cantell, & K. Mattson. (1990). Natural Interferon-Alpha Alone and in Combination with Conventional Therapies in Non-Small Cell Lung Cancer. Acta Oncologica. 29(7). 927–930. 7 indexed citations
10.
Niiranen, A., M Kajanti, L. Tammilehto, & K. Mattson. (1990). The Clinical Effect of Medroxyprogesterone (MPA) in Elderly Patients with Lung Cancer. American Journal of Clinical Oncology. 13(2). 113–116. 5 indexed citations
11.
Niiranen, A., Paul Holsti, & M Salmo. (1989). Treatment of Small Cell Lung Cancer: Two-drug versus four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiation. Acta Oncologica. 28(4). 501–505. 35 indexed citations
12.
Färkkilâ, Martti, M. Iivanainen, Matti Härkönen, et al.. (1988). Effect of Interferon-γ on Biogenic Amine Metabolism, Electroencephalographic Recordings, and Transient Potentials. Clinical Neuropharmacology. 11(1). 63–67. 14 indexed citations
13.
Niiranen, A., Ritva Laaksonen, M. Livanainen, et al.. (1988). Behavioral assessment of patients treated with alpha‐interferon. Acta Psychiatrica Scandinavica. 78(5). 622–626. 52 indexed citations
14.
Niiranen, A.. (1988). Long-term survival in small cell carcinoma of the lung. European Journal of Cancer and Clinical Oncology. 24(4). 749–752. 20 indexed citations
15.
Laaksonen, Ritva, A. Niiranen, M Iivanainen, et al.. (1988). Dementia-like, largely reversible syndrome after cranial irradiation and prolonged interferon treatment.. PubMed. 20(3). 201–3. 4 indexed citations
16.
Holsti, Lars R., K. Mattson, A. Niiranen, et al.. (1987). Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung. International Journal of Radiation Oncology*Biology*Physics. 13(8). 1161–1166. 58 indexed citations
17.
Niiranen, A., et al.. (1987). Vincristine-Cyclophosphamide, the Classical Two-Drug Regimen for Small-Cell Lung Cancer, Evaluated in a Randomized Study with Vindesine. American Journal of Clinical Oncology. 10(6). 507–511. 4 indexed citations
18.
Niiranen, A. & K. Mattson. (1987). Antiemetic Efficacy of Nabilone and Dexamethasone. American Journal of Clinical Oncology. 10(4). 325–329. 22 indexed citations
19.
Mattson, K., A. Niiranen, L. Kivisaari, et al.. (1985). Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer.. PubMed. 4(1). 8–17. 26 indexed citations
20.
Niiranen, A. & K. Mattson. (1985). A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. American Journal of Clinical Oncology. 8(4). 336–340. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia L. Villegas Breakdown of academic impact, for papers by Renata Talar‐Wojnarowska Breakdown of academic impact, for papers by Carlos Vargas Breakdown of academic impact, for papers by Fausto Rossini Breakdown of academic impact, for papers by Manabu Nagata Breakdown of academic impact, for papers by Richard Petrillo Breakdown of academic impact, for papers by Franca Marino Breakdown of academic impact, for papers by Pelayo González Breakdown of academic impact, for papers by Helen Gray
Rankless by CCL
2026